The clinical implications and management of concomitant hypertension and dyslipidemia.
Hypertension and dyslipidemia often coexist, increasing the risk of cardiovascular disease. Evidence suggesting that concomitant hypertension and dyslipidemia are compelling candidates for a unified approach to treating cardiovascular risk is reviewed in this article. The authors also discuss important new findings documenting the need for, and benefits of, a more integrated approach to treating this dangerous duo.
Nash
David T
DT
State University of New York at Syracuse, Upstate Medical Center, USA. davidtnash@aol.com
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D050171:Dyslipidemias / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors